AAPL 167.04 -0.5714% MSFT 404.33 -1.8235% GOOG 157.46 0.3697% GOOGL 155.9725 0.3232% AMZN 179.17 -1.1639% NVDA 846.71 0.7568% META 501.8 1.544% TSLA 149.9 -3.5703% TSM 132.27 -4.8623% LLY 745.95 -0.642% V 271.36 -0.4877% AVGO 1258.99 -1.8431% JPM 181.25 0.6497% UNH 493.18 2.9625% NVO 122.75 -1.4294% WMT 59.27 -0.637% LVMUY 170.18 -0.3338% XOM 118.47 -0.1349% LVMHF 854.0 -0.4662% MA 454.7 -1.1865%

Hims Hers Health Inc

Consumer Defensive US HIMS

12.34USD
-0.07(0.56%)

Last update at 2024-04-18T20:10:00Z

Day Range

12.1412.63
LowHigh

52 Week Range

5.6512.34
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -65.70900M -110.79500M -17.98700M -71.97400M -
Minority interest - - - - -
Net income -65.67800M -107.65900M -18.11400M -72.06400M -
Selling general administrative 98.19M 183.63M 65.61M 55.86M -
Selling and marketing expenses 272.59M 135.90M 58.99M 63.16M -
Gross profit 408.72M 204.49M 109.45M 44.60M -
Reconciled depreciation 7.47M 4.08M 1.06M 0.26M -
Ebit -68.69700M -115.04200M -15.14400M -74.41400M -75.76900M
Ebitda -61.22300M -110.52200M -16.92000M -72.29600M -
Depreciation and amortization 7.47M 4.52M -1.77600M 2.12M -
Non operating income net other - 4.25M 3.14M - -
Operating income -68.69700M -115.04200M -15.14400M -74.41400M -
Other operating expenses 595.61M 386.92M 163.90M 156.97M -
Interest expense 2.99M 3.80M 0.01000M 0.37M 0.00000M
Tax provision -0.03100M -3.13600M 0.13M 0.09M -
Interest income - - - - -
Net interest income - 0.00000M -0.01000M -0.36900M -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -0.03100M -3.13600M 0.13M 0.09M 0.04M
Total revenue 526.92M 271.88M 148.76M 82.56M -
Total operating expenses 477.42M 319.54M 124.59M 119.02M -
Cost of revenue 118.19M 67.38M 39.31M 37.95M -
Total other income expense net 2.99M 4.25M -2.84300M 2.44M -
Discontinued operations - - - - -
Net income from continuing ops -65.67800M -107.65900M -3.04901M -72.06400M -
Net income applicable to common shares -65.67800M -107.65900M -18.11400M -72.06400M -75.24300M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 366.34M 420.58M 118.70M 72.07M -
Intangible assets 21.84M 25.89M 0.06M - -
Earning assets - - - - -
Other current assets 15.41M 9.07M 0.17M 0.48M 0.99M
Total liab 54.60M 85.97M 265.57M 207.36M -
Total stockholder equity 311.74M 334.62M -146.87400M -135.29300M -
Deferred long term liab - - - - -
Other current liab 12.45M 55.03M 1.57M 11.12M 0.90M
Common stock 0.02M 0.02M 0.00500M 4.50M -
Capital stock 0.02M 0.02M 0.00500M 4.50M -
Retained earnings -344.62900M -278.95100M -171.29200M -153.17800M -81.11400M
Other liab 3.01M 2.63M 0.38M 4.50M -
Good will 110.88M 110.88M 0.00000M - -
Other assets 0.89M 8.80M 1.01M 0.96M 0.18M
Cash 46.77M 71.78M 27.34M 22.65M -
Cash and equivalents - - - - -
Total current liabilities 47.94M 79.22M 15.23M 20.62M 24.11M
Current deferred revenue 1.47M 3.19M 1.27M 0.75M -
Net debt -41.46500M -66.30200M -27.34400M -21.13200M -
Short term debt 1.66M 1.36M 4.32M 1.51M -
Short long term debt - - - 1.51M -
Short long term debt total 5.31M 5.48M - 1.51M -
Other stockholder equity 656.63M 613.69M 24.42M 13.38M -0.00200M
Property plant equipment 7.94M 5.11M 1.70M 0.20M -
Total current assets 216.59M 269.90M 113.08M 69.61M 47.34M
Long term investments - - 204.53M 203.11M -
Net tangible assets 170.82M 197.85M -149.77400M -141.09300M -71.35700M
Short term investments 132.85M 175.49M 72.86M 37.72M -
Net receivables 3.23M 3.58M 1.15M 0.86M 0.50M
Long term debt - - - - -
Inventory 21.56M 13.56M 3.54M 4.22M 3.69M
Accounts payable 32.36M 19.64M 8.07M 7.23M 13.31M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -0.27700M -0.13700M -0.01100M 0.00200M -
Additional paid in capital - - - - -
Common stock total equity - 0.02M 188.54M 181.24M -
Preferred stock total equity - - - - -
Retained earnings total equity - -278.95100M -1.90175M - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 12.09M 8.80M -198.97106M 2.46M -
Deferred long term asset charges - - - - -
Non current assets total 149.75M 150.68M 5.61M 2.46M -
Capital lease obligations 5.31M 5.48M 0.00000M - -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments 34.70M -104.79300M -35.46800M -37.51200M -37.51200M
Change to liabilities 11.01M 11.27M 1.34M -5.86300M 13.38M
Total cashflows from investing activities 34.70M -156.26800M -39.70100M -39.29900M -0.00800M
Net borrowings - 1.19M -1.51500M -6.91500M 7.43M
Total cash from financing activities -33.12700M 235.04M 47.74M 95.32M 78.15M
Change to operating activities -17.19800M 1.82M 2.17M -3.46700M 0.26M
Net income -65.67800M -107.65900M -18.11400M -72.06400M -75.24300M
Change in cash -25.01200M 44.29M 5.55M -18.85300M 20.82M
Begin period cash flow 72.64M 28.35M 22.80M 41.65M -
End period cash flow 47.63M 72.64M 28.35M 22.80M 41.65M
Total cash from operating activities -26.53100M -34.41200M -2.47900M -74.86700M -57.32200M
Issuance of capital stock 0.00000M 272.69M 51.90M 102.57M -
Depreciation 7.47M 4.08M 1.06M 0.26M 0.26M
Other cashflows from investing activities - -51.47500M 0.33M - -
Dividends paid - - 1.74M - -
Change to inventory -8.00400M -9.62800M 0.67M -0.52200M -2.99700M
Change to account receivables - 1.82M 1.79M -3.46700M -
Sale purchase of stock 0.00000M -22.02700M 0.00000M 0.00000M -
Other cashflows from financing activities -35.37300M -15.61600M 51.00M 104.37M -0.23700M
Change to netincome 45.87M 65.57M 10.07M 6.72M 7.28M
Capital expenditures 7.25M 5.01M 4.23M 1.79M 0.00800M
Change receivables - - - - -
Cash flows other operating - 4.54M -2.06389M - -
Exchange rate changes - -0.07300M - - -
Cash and cash equivalents changes - 44.29M -0.45207M - -
Change in working capital -14.19500M 3.46M 4.19M -9.85200M -
Stock based compensation 42.82M 67.21M 5.83M 8.03M -
Other non cash items 3.65M 1.89M 4.56M -1.03900M -
Free cash flow -33.77800M -39.41900M -6.71200M -76.65400M -

Fundamentals

  • Previous Close 12.41
  • Market Cap1854.95M
  • Volume3548786
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-30.17000M
  • Revenue TTM792.58M
  • Revenue Per Share TTM3.81
  • Gross Profit TTM 408.72M
  • Diluted EPS TTM-0.17

Peer Comparison

Sector: Consumer Defensive Industry: Household & Personal Products

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
HIMS
Hims Hers Health Inc
-0.07 0.56% 12.34 - 35.59 2.34 5.58 2.28 -37.1743
PG
Procter & Gamble Company
1.34 0.86% 157.29 23.58 22.62 4.07 7.24 4.40 16.08
LRLCF
L'Oréal S.A
11.35 2.55% 457.05 41.14 34.25 6.52 8.59 6.67 27.76
LRLCY
L’Oreal Co ADR
4.96 5.57% 94.06 41.27 33.90 6.56 8.50 6.65 27.67
UL
Unilever PLC ADR
0.16 0.34% 46.85 13.41 15.48 1.95 5.63 2.38 10.29

Reports Covered

Stock Research & News

Profile

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.

Hims Hers Health Inc

2269 Chestnut Street, San Francisco, CA, United States, 94123

Key Executives

Name Title Year Born
Mr. Andrew Dudum Co-Founder, Chairman & CEO 1989
Ms. Melissa Baird Chief Operations Officer 1978
Ms. Irene A. Becklund Principal Accounting Officer 1985
Ms. Soleil Teubner Boughton Chief Legal Officer & Corp. Sec. 1979
Mr. Yemi Okupe Chief Financial Officer 1986
Mr. Brian O'Shaughnessy Chief Communications Officer NA
Ms. Amee Parekh Sr. VP of HR NA
Mr. Mike Chi Chief Growth Officer NA
Mr. Jonathan Spitzer C.F.A. Sr. VP of Investor Relations NA
Dr. Aimee Paik FAAD, M.D. Sr. VP & Member of Medical Advisory Board NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).